The p53 gene is a recessive oncogene whose loss of function can result
in cell transformation, Approximately 25% of human breast cancers con
tain missense mutations in one p53 allele, leading to inactivation of
the mutated protein. In almost all of these cases, the wild-type allel
e is also lost, However, it remains uncertain whether mutant p53 acts
in a dominant negative fashion over the wild-type protein, Two paramet
ers of p53 function, transcriptional activation and transcriptional re
pression, were studied under a variety of experimental conditions with
in malignant and normal breast epithelial cells, Transient transfectio
n of DNA encoding wild-type p53 was able to transactivate p53-responsi
ve promoters, Wild-type p53 functioned equally wed in malignant cells
which harbored an endogenous mutation in p53, in malignant cells conta
ining normal p53 and in normal mammary epithelial cells, Co-transfecti
on of cDNAs encoding mutant p53 proteins mere unable to inhibit the ab
ility of wild-type p53 to transactivate the reporter constructs, Repre
ssion of viral promoters by normal p53 protein was not inhibited trans
fected mutant p53 proteins, regulated gene WBF1/CIP1/p21 was induced f
ollowing gamma irradiation in normal mammary cells, containing endogen
ous wild-type p53 and in the same cells transfected with mutant p53 ge
nes, From these experiments me conclude that mutant p53 proteins do no
t inactivate the transactivating (or repressing) function of a co-expr
essed normal p53 protein in these cells implying that complete loss of
mild-type p53 is required to eliminate these functions in breast epit
helium.